Blog Archives

ImmuPharma’s Lupuzor fails to meet the primary endpoint in its phase 3 trial

I woke to extremely disappointing news this morning. In my Hope for 2016 post, I mentioned peptide based drugs as my #2 hope, with Lupuzor being the key candidate. Over the past several years, I have watched the Lupuzor trials

Posted in Clinical Trials, Treatment Tagged with: ,

Hope for 2016 – 5 upcoming treatments for Sjogren’s Syndrome

Happy new year everyone! Holiday and new years celebrations tend to evoke a lot of memories for me, particularly of healthier times before SS symptoms. In an effort to focus on the positive, I decided to look over promising treatment

Posted in Clinical Trials, Research, Treatment Tagged with: , ,
WordPress Appliance - Powered by TurnKey Linux